Long-term outcomes of renal denervation and related sex characteristics: data from a three-year follow-up

Aim. To study the long-term outcomes of renal denervation (RDN) within 3-year follow-up with an assessment of blood pressure (BP) changes, the severity of target organ damage and the levels of pro- and anti-inflammatory cytokines in patients with resistant hypertension (RH), taking into account sex...

Full description

Bibliographic Details
Main Authors: I. V. Zyubanova, V. F. Mordovin, A. Yu. Falkovskaya, S. E. Pekarsky, T. M. Ripp, M. A. Manukyan, V. A. Lichikaki, A. M. Gusakova, T. R. Ryabova, A. E. Baev
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2021-05-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/4006
id doaj-5894cbb58af544ffa84b46e0b1c69da0
record_format Article
spelling doaj-5894cbb58af544ffa84b46e0b1c69da02021-07-28T14:02:41Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202021-05-0126410.15829/1560-4071-2021-40063083Long-term outcomes of renal denervation and related sex characteristics: data from a three-year follow-upI. V. Zyubanova0V. F. Mordovin1A. Yu. Falkovskaya2S. E. Pekarsky3T. M. Ripp4M. A. Manukyan5V. A. Lichikaki6A. M. Gusakova7T. R. Ryabova8A. E. Baev9Cardiology Research Institute, Tomsk National Research Medical CenterCardiology Research Institute, Tomsk National Research Medical CenterCardiology Research Institute, Tomsk National Research Medical CenterCardiology Research Institute, Tomsk National Research Medical CenterCardiology Research Institute, Tomsk National Research Medical CenterCardiology Research Institute, Tomsk National Research Medical CenterCardiology Research Institute, Tomsk National Research Medical CenterCardiology Research Institute, Tomsk National Research Medical CenterCardiology Research Institute, Tomsk National Research Medical CenterCardiology Research Institute, Tomsk National Research Medical CenterAim. To study the long-term outcomes of renal denervation (RDN) within 3-year follow-up with an assessment of blood pressure (BP) changes, the severity of target organ damage and the levels of pro- and anti-inflammatory cytokines in patients with resistant hypertension (RH), taking into account sex characteristics.Material and methods. A total of 42 patients with RH were examined at baseline, 1, 2, and 3 years after RDN on the background of antihypertensive therapy. Twenty-four-hour BP monitoring, echocardiography, assessment of creatinine level and estimated glomerular filtration rate (eGFR), as well as determination of some cytokines (interleukin (IL)-1β, 6, 10, tumor necrosis factor-α) were performed.Results. There was a persistent BP decrease in men and women for three years compared with the initial level by an average of 17 [4; 31]/10 [0; 18] mm Hg (p<0,05). Decrease in BP variability from 17,9±5,1 to 15,2±3,6 mm Hg was observed mainly by means of women, while the decrease in left ventricular mass from 250,4±64,0 to 229,3±61,9 g was mainly by means of men. Creatinine level was unchanged, while eGFR decreased from 78,8±16,1 to 74,5±20,3 ml/ min/1,73 m2 over 3 years; the mean eGFR decline was 1,4 ml/min/1,73 m2 in year. All studied cytokines tended to decrease regardless of sex: tumor necrosis factor-α — from 2,1 [1,2; 77] to 2,1 [1,7; 2,6] pg/ml (p=0,022); IL-1β — from 2,2 [1,5; 2,4] to 1,6 [1,1; 1,5] pg/ml (p=0,034); IL-6 — from 3,8 [1,6; 4,9] to 2,8 [1,8; 3,0] pg/ml (p>0,05), IL-10 — from 5,8 [3,2; 8,2] to 2,8 [2,6; 2,9] pg/ml (p=0,000), correlating with IL-6 dynamics.Conclusion. Three years after RDN, there is a persistent decrease in mean 24-hour BP, regardless of sex. In women, a more pronounced BP variability decrease is observed, while in men — regression of left ventricular mass. There is no significant decrease in eGFR in the long-term period. The decrease in proinflammatory cytokines maintains, and in some cases becomes more pronounced within three years after RDN.https://russjcardiol.elpub.ru/jour/article/view/4006resistant hypertensionrenal denervationorgan protectionproin-flammatory cytokines
collection DOAJ
language Russian
format Article
sources DOAJ
author I. V. Zyubanova
V. F. Mordovin
A. Yu. Falkovskaya
S. E. Pekarsky
T. M. Ripp
M. A. Manukyan
V. A. Lichikaki
A. M. Gusakova
T. R. Ryabova
A. E. Baev
spellingShingle I. V. Zyubanova
V. F. Mordovin
A. Yu. Falkovskaya
S. E. Pekarsky
T. M. Ripp
M. A. Manukyan
V. A. Lichikaki
A. M. Gusakova
T. R. Ryabova
A. E. Baev
Long-term outcomes of renal denervation and related sex characteristics: data from a three-year follow-up
Российский кардиологический журнал
resistant hypertension
renal denervation
organ protection
proin-flammatory cytokines
author_facet I. V. Zyubanova
V. F. Mordovin
A. Yu. Falkovskaya
S. E. Pekarsky
T. M. Ripp
M. A. Manukyan
V. A. Lichikaki
A. M. Gusakova
T. R. Ryabova
A. E. Baev
author_sort I. V. Zyubanova
title Long-term outcomes of renal denervation and related sex characteristics: data from a three-year follow-up
title_short Long-term outcomes of renal denervation and related sex characteristics: data from a three-year follow-up
title_full Long-term outcomes of renal denervation and related sex characteristics: data from a three-year follow-up
title_fullStr Long-term outcomes of renal denervation and related sex characteristics: data from a three-year follow-up
title_full_unstemmed Long-term outcomes of renal denervation and related sex characteristics: data from a three-year follow-up
title_sort long-term outcomes of renal denervation and related sex characteristics: data from a three-year follow-up
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2021-05-01
description Aim. To study the long-term outcomes of renal denervation (RDN) within 3-year follow-up with an assessment of blood pressure (BP) changes, the severity of target organ damage and the levels of pro- and anti-inflammatory cytokines in patients with resistant hypertension (RH), taking into account sex characteristics.Material and methods. A total of 42 patients with RH were examined at baseline, 1, 2, and 3 years after RDN on the background of antihypertensive therapy. Twenty-four-hour BP monitoring, echocardiography, assessment of creatinine level and estimated glomerular filtration rate (eGFR), as well as determination of some cytokines (interleukin (IL)-1β, 6, 10, tumor necrosis factor-α) were performed.Results. There was a persistent BP decrease in men and women for three years compared with the initial level by an average of 17 [4; 31]/10 [0; 18] mm Hg (p<0,05). Decrease in BP variability from 17,9±5,1 to 15,2±3,6 mm Hg was observed mainly by means of women, while the decrease in left ventricular mass from 250,4±64,0 to 229,3±61,9 g was mainly by means of men. Creatinine level was unchanged, while eGFR decreased from 78,8±16,1 to 74,5±20,3 ml/ min/1,73 m2 over 3 years; the mean eGFR decline was 1,4 ml/min/1,73 m2 in year. All studied cytokines tended to decrease regardless of sex: tumor necrosis factor-α — from 2,1 [1,2; 77] to 2,1 [1,7; 2,6] pg/ml (p=0,022); IL-1β — from 2,2 [1,5; 2,4] to 1,6 [1,1; 1,5] pg/ml (p=0,034); IL-6 — from 3,8 [1,6; 4,9] to 2,8 [1,8; 3,0] pg/ml (p>0,05), IL-10 — from 5,8 [3,2; 8,2] to 2,8 [2,6; 2,9] pg/ml (p=0,000), correlating with IL-6 dynamics.Conclusion. Three years after RDN, there is a persistent decrease in mean 24-hour BP, regardless of sex. In women, a more pronounced BP variability decrease is observed, while in men — regression of left ventricular mass. There is no significant decrease in eGFR in the long-term period. The decrease in proinflammatory cytokines maintains, and in some cases becomes more pronounced within three years after RDN.
topic resistant hypertension
renal denervation
organ protection
proin-flammatory cytokines
url https://russjcardiol.elpub.ru/jour/article/view/4006
work_keys_str_mv AT ivzyubanova longtermoutcomesofrenaldenervationandrelatedsexcharacteristicsdatafromathreeyearfollowup
AT vfmordovin longtermoutcomesofrenaldenervationandrelatedsexcharacteristicsdatafromathreeyearfollowup
AT ayufalkovskaya longtermoutcomesofrenaldenervationandrelatedsexcharacteristicsdatafromathreeyearfollowup
AT sepekarsky longtermoutcomesofrenaldenervationandrelatedsexcharacteristicsdatafromathreeyearfollowup
AT tmripp longtermoutcomesofrenaldenervationandrelatedsexcharacteristicsdatafromathreeyearfollowup
AT mamanukyan longtermoutcomesofrenaldenervationandrelatedsexcharacteristicsdatafromathreeyearfollowup
AT valichikaki longtermoutcomesofrenaldenervationandrelatedsexcharacteristicsdatafromathreeyearfollowup
AT amgusakova longtermoutcomesofrenaldenervationandrelatedsexcharacteristicsdatafromathreeyearfollowup
AT trryabova longtermoutcomesofrenaldenervationandrelatedsexcharacteristicsdatafromathreeyearfollowup
AT aebaev longtermoutcomesofrenaldenervationandrelatedsexcharacteristicsdatafromathreeyearfollowup
_version_ 1721268795594506240